Literature DB >> 3786735

Observation of metabolites in the human brain by MR spectroscopy.

P R Luyten, J A den Hollander.   

Abstract

Measurement of low molecular weight metabolites by hydrogen magnetic resonance (MR) spectroscopy is complicated by the presence of intense signals from water and lipids. A method of spatially resolved spectroscopy (SPARS), combined with techniques to suppress water signal, was used to overcome this problem. By means of SPARS, a signal can be obtained from a particular volume only, with no signal from the rest of the sample. Thus, a volume in the brain can be selected, and intense lipid signals from other tissue are suppressed. The SPARS technique is based on the use of pulsed magnetic field gradients, which makes it possible to select the sensitive volume on the basis of an MR image. Suppression of the intense water signal was achieved by applying a 1331 observation pulse. With these techniques, N-acetyl aspartate was successfully measured in the human brain with a 1.5-T whole-body imager, and lactate was observed in excised brain tissue of a pig. Measurement of low molecular weight metabolites has potential significance in evaluating patients with diseases of the brain; further studies are underway to assess this potential.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3786735     DOI: 10.1148/radiology.161.3.3786735

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

Review 1.  Recent advances in magnetic resonance neurospectroscopy.

Authors:  Yael Rosen; Robert E Lenkinski
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

2.  Newfound effect of N-acetylaspartate in preventing and reversing aggregation of amyloid-beta in vitro.

Authors:  Jean-Pierre Dollé; Jeffrey M Rodgers; Kevin D Browne; Thomas Troxler; Feng Gai; Douglas H Smith
Journal:  Neurobiol Dis       Date:  2018-05-31       Impact factor: 5.996

Review 3.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

4.  Combined T2 -preparation and multidimensional outer volume suppression for coronary artery imaging with 3D cones trajectories.

Authors:  David Y Zeng; Corey A Baron; Mario O Malavé; Adam B Kerr; Phillip C Yang; Bob S Hu; Dwight G Nishimura
Journal:  Magn Reson Med       Date:  2019-11-05       Impact factor: 4.668

Review 5.  Clinical Applications of Magnetic Resonance Spectroscopy in Brain Tumors: From Diagnosis to Treatment.

Authors:  Brent D Weinberg; Manohar Kuruva; Hyunsuk Shim; Mark E Mullins
Journal:  Radiol Clin North Am       Date:  2021-03-23       Impact factor: 2.303

6.  Elevated cerebrospinal fluid concentrations of N-acetylaspartate correlate with poor outcome in a pilot study of severe brain trauma.

Authors:  Nicole D Osier; Melody Ziari; Ava M Puccio; Samuel Poloyac; David O Okonkwo; Margaret B Minnigh; Sue R Beers; Yvette P Conley
Journal:  Brain Inj       Date:  2019-07-15       Impact factor: 2.311

7.  The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus.

Authors:  William M Brooks; Wilmer L Sibbitt; Mario Kornfeld; Rex E Jung; Arthur D Bankhurst; Carlos A Roldan
Journal:  Arthritis Rheum       Date:  2010-07

8.  Measuring N-acetylaspartate synthesis in vivo using proton magnetic resonance spectroscopy.

Authors:  Su Xu; Jehoon Yang; Jun Shen
Journal:  J Neurosci Methods       Date:  2008-04-10       Impact factor: 2.390

9.  A 'complex' of brain metabolites distinguish altered chemistry in the cingulate cortex of episodic migraine patients.

Authors:  L Becerra; R Veggeberg; A Prescot; J E Jensen; P Renshaw; S Scrivani; E L H Spierings; R Burstein; D Borsook
Journal:  Neuroimage Clin       Date:  2016-03-31       Impact factor: 4.881

10.  N-acetylaspartate reduction in the medial prefrontal cortex following 8 weeks of risperidone treatment in first-episode drug-naïve schizophrenia patients.

Authors:  Xiaofen Zong; Maolin Hu; Zongchang Li; Hongbao Cao; Ying He; Yanhui Liao; Jun Zhou; Deen Sang; Hongzeng Zhao; Jinsong Tang; Luxian Lv; Xiaogang Chen
Journal:  Sci Rep       Date:  2015-03-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.